CODXCo-Diagnostics, Inc.
6.039USD-31.29%Mkt Cap: 22.46M USDP/E: Last update: 2026-06-01

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in …

Indicators:|

Key Statistics

Company
Market Cap22.46M USD
Enterprise Value24.53M USD
Revenue (TTM)718.17K USD
Gross Profit400.11K USD
Net Income (TTM)-46.90M USD
Revenue/Share0.4420 USD
Last Price6.039 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees115
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS1897631057
Valuation
P/E (Trailing)
P/E (Forward)-0.71
PEG
EV/EBITDA-0.80
EV/Revenue34.15
P/S43.77
P/B1.92
EPS (TTM)-32.26
EPS (Forward)-12.00
52W Range
1.26011% of range46.50
52W High46.50 USD
52W Low1.260 USD
Profitability
Gross Margin64.28%
Oper. Margin-6309.12%
EBITDA Margin0.00%
Profit Margin-7533.62%
ROE-227.33%
ROA-189.54%
Growth
Revenue Growth190.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-29.14M USD
CapEx (TTM)700.05K USD
FCF Margin
FCF Yield
Net Debt-6.20M USD
Net Debt/EBITDA0.20
Balance Sheet
Debt/Equity0.06
Current Ratio2.28
Quick Ratio1.94
Book Value/Sh4.453 USD
Cash/Share2.285 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.3.66M
Float3.50M
Insiders3.28%
Institutions1.35%
Short Interest
Short Ratio0.3d
Short % Float5.58%
Short % Out.5.39%
Shares Short194.18K
Short (prev mo.)45.70K
Technical
SMA 502.296 (+163.1%)
SMA 2006.642 (-9.1%)
Beta
S&P 52W Chg27.94%
Avg Vol (30d)11.00M
Avg Vol (10d)31.45M
Technical Indicators
RSI (14)65.2
MACD1.8602
MACD Signal0.9336
MACD Hist.+0.9266
BB Upper10.11 USD
BB Middle3.580 USD
BB Lower-2.9544 USD
BB Width365.05%
ATR (14)1.879 USD
Vol Ratio (20d)0.19x